canada bpc 157 BPC-157 Peptide BPC-157 Canada | 10mg &

benefit: FDA only looked at risk, ignored benefits Off-label use: Doctors prescribe drugs off-label all the time Patient access: People are suffering and need options Regulatory capture: Big Pharma doesn't want cheap peptides competing The problem with these arguments: It's NOT off-label use Off-label only applies to FDA-approved drugs

BCP-157

They may support recovery by signaling repair pathways, but much of the evidence is still preclinical, so benefits are best described as supportive rather than proven

The first is during the initial titration phase, when the body is adjusting to a new medication that fundamentally changes how the digestive system operates

Always Consult Your GP/Healthcare Professional: This cannot be stressed enough